Illumina Other Income (Expense) decreased by 129.5% to -$52.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 388.9%, from $18.00M to -$52.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -27.4% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.00M | $965.00M | $45.00M | -$44.00M | -$58.00M | -$15.00M | -$41.00M | -$14.00M | -$1.00M | -$28.00M | -$3.00M | $2.00M | -$339.00M | -$21.00M | $0.00 | $18.00M | $92.00M | -$7.00M | $176.00M | -$52.00M |
| QoQ Change | — | >999% | -95.3% | -197.8% | -31.8% | +74.1% | -173.3% | +65.9% | +92.9% | <-999% | +89.3% | +166.7% | <-999% | +93.8% | +100.0% | — | +411.1% | -107.6% | >999% | -129.5% |
| YoY Change | — | — | — | — | -390.0% | -101.6% | -191.1% | +68.2% | +98.3% | -86.7% | +92.7% | +114.3% | <-999% | +25.0% | +100.0% | +800.0% | +127.1% | +66.7% | — | -388.9% |